REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
13.95
-1.70 (-10.86%)
Jul 10, 2026, 4:00 PM EDT - Market closed
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $721.2 million as of July 10, 2026. Its market cap has increased by 68.35% in one year.
Market Cap
721.20M
Enterprise Value
819.10M
1-Year Change
68.35%
Ranking
Category
Stock Price
$13.95
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $721.20M, a decrease of -3.75%. That is a compound annual growth rate of -0.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 721.20M | -1.07% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SL Science Holding | 764.49M |
| Bright Minds Biosciences | 754.68M |
| Aura Biosciences | 754.45M |
| SpyGlass Pharma | 752.92M |
| Omeros | 744.02M |
| Gyre Therapeutics | 726.91M |
| Monopar Therapeutics | 714.09M |
| Candel Therapeutics | 695.33M |